159 assets in Cervical Cancer

Therapeutic assets addressing Cervical Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Tsc-203-A0201 Cervical Cancer	TScan Therapeutics, Inc.	P1	C (37)
Tsc-204-A0101 Cervical Cancer	TScan Therapeutics, Inc.	P1	C (37)
Tsc-204-A0201 Cervical Cancer	TScan Therapeutics, Inc.	P1	C (37)
Tsc-204-C0702 Cervical Cancer	TScan Therapeutics, Inc.	P1	C (37)
vet3-tgi Cervical Cancer	KaliVir Immunotherapeutics	P1	C (37)
Slv-154 Cervical Cancer	Solve Therapeutics	P1	NR ()
Volrustomig Cervical Cancer	AstraZeneca	P2	NR ()

Showing 151 to 159 of 159 assets

PreviousPage 4 of 4Next